1. "Solid Tumor Oncology Division"
Formats
  1. Journal Article (10831)
  2. Meeting Abstract (9435)
  3. Review (542)
  4. Book Section (410)
  5. Editorial (324)
  6. Guidelines (154)
  7. Correspondence (115)
  8. Conference Paper (106)
  9. Research Letter (60)
  10. Miscellaneous (53)
  11. Book Whole (27)
Groups
  1. Solid Tumor Oncology Division (22057)
  2. Department of Medicine (22035)
  3. GSK Faculty (5880)
  4. Genitourinary Oncology Service (5608)
  5. Survivorship Research (5184)
  6. Gastrointestinal Oncology Service (4640)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. Clifford Hudis (905)
  4. Jedd Wolchok (905)
  5. Mark Kris (869)
  6. Leonard Saltz (790)

More People

Years
  1. 2025 (445)
  2. 2024 (1382)
  3. 2023 (1380)
  4. 2022 (1573)
  5. 2021 (1517)
  6. 2020 (1535)

More Years

Publications
  1. Journal of Clinical Oncology (5227)
  2. Annals of Oncology (1294)
  3. Cancer Research (1012)
  4. Clinical Cancer Research (768)
  5. Journal of Thoracic Oncology (530)
  6. Gynecologic Oncology (441)

More Publications

Publishers
  1. American Society of Clinical Oncology (5507)
  2. Elsevier Inc. (2651)
  3. American Association for Cancer Research (2316)
  4. Oxford University Press (1810)
  5. Nature Publishing Group (1026)
  6. Springer (975)

More Publishers

Results (22057)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Avelumab in chemotherapy-refractory metastatic Merkel cell carcinoma: Subgroup analysis of efficacy
    Meeting Abstract

    Kaufman, H. L.; Russell, J.; Hamid, O.; Bhatia, S.; Terheyden, P.; D'Angelo, S. P.; Shih, K. C.; Lebbe, C.; Linette, G. P.; Milella, M.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Brain metastases (BM) in pancreatic ductal adenocarcinoma (PDAC): Clinical and molecular characteristics
    Meeting Abstract

    Jordan, E.; Kaley, T. J.; Capanu, M.; Estrella, H.; Leach, S. D.; Basturk, O.; Klimstra, D. S.; Allen, P. J.; Berger, M. F.; Yu, K. H.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Restoration of tumor suppression in vivo by systemic delivery of chemically-modified PTEN mRNA nanoparticles
    Meeting Abstract

    Islam, M. A.; Xu, Y.; Zope, H.; Cao, W.; Mahmoudi, M.; Langer, R.; Kantoff, P. W.; Shi, J.; Zetter, B. R.; Farokhzad, O. C.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Phase II study of gemcitabine (G), trastuzumab (H), and pertuzumab (P) for HER2-positive metastatic breast cancer (MBC) after prior pertuzumab-based therapy
    Meeting Abstract

    Iyengar, N. M.; Smyth, L. M.; Lake, D.; Gucalp, A.; Singh, J. C.; Traina, T. A.; DeFusco, P. A.; Dickler, M. N.; Fornier, M. N.; Goldfarb, S. B.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Two randomized, placebo-controlled phase 3 studies of ruxolitinib (Rux) + capecitabine (C) in patients (pts) with advanced/metastatic pancreatic cancer (mPC) after failure/intolerance of first-line chemotherapy: JANUS 1 (J1) and JANUS 2 (J2)
    Meeting Abstract

    Hurwitz, H.; Van Cutsem, E.; Bendell, J. C.; Hidalgo, M.; Li, C. P.; Garrido, M.; Macarulla, T. M.; Sahai, V.; Sama, A. R.; Greeno, E.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Vemurafenib in patients with BRAF(V600) mutant glioma: A cohort of the histology-independent VE-basket study
    Meeting Abstract

    Hyman, D. M.; Kaley, T. J.; Hollebecque, A.; Subbiah, V.; Ahnert, J. R.; Lockhart, A. C.; Keedy, V. L.; Hofheinz, R.; Lobbedez, F. J.; Blay, J. Y.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • The efficacy of larotrectinib (LOXO-101), a selective tropomyosin receptor kinase (TRK) inhibitor, in adult and pediatric TRK fusion cancers
    Meeting Abstract

    Hyman, D. M.; Laetsch, T. W.; Kummar, S.; DuBois, S. G.; Farago, A. F.; Pappo, A. S.; Demetri, G. D.; El-Deiry, W. S.; Lassen, U. N.; Dowlati, A.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Overall survival (OS) analysis from an expanded access program (EAP) of nivolumab (NIVO) in combination with ipilimumab (IPI) in patients with advanced melanoma (MEL)
    Meeting Abstract

    Hogg, D.; Chapman, P. B.; Sznol, M.; Lao, C. D.; Gonzalez, R.; Daniels, G. A.; Smylie, M.; Kudchadkar, R. R.; Thompson, J. A.; Sharfman, W. H.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Clinical characterization of pancreatic ductal adenocarcinomas (PDAC) with mismatch repair (MMR) gene mutations
    Meeting Abstract

    Hu, Z. I.; Varghese, A. M.; Shia, J.; Zervoudakis, A.; Lowery, M. A.; Yu, K. H.; Chalasani, S. B.; Robson, M. E.; Stadler, Z. K.; Caron, P.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Visceral thromboses (VT) in pancreas adenocarcinoma (PDAC): A systematic review
    Meeting Abstract

    Hicks, A. M.; Derosa, A.; Raj, M.; Do, R. K. G.; Yu, K. H.; Lowery, M. A.; Varghese, A. M.; O'Reilly, E. M.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save